Aquestive Therapeutics, Inc. Annual Interest Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Aquestive Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2017 to 2023.
  • Aquestive Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $2.78M, a 102% increase year-over-year.
  • Aquestive Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $9.09M, a 48.9% increase year-over-year.
  • Aquestive Therapeutics, Inc. annual Interest Expense for 2023 was $6.34M, a 3.28% decline from 2022.
  • Aquestive Therapeutics, Inc. annual Interest Expense for 2022 was $6.55M, a 34.8% decline from 2021.
  • Aquestive Therapeutics, Inc. annual Interest Expense for 2021 was $10M, a 9.17% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.34M -$215K -3.28% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $6.55M -$3.5M -34.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $10M -$1.02M -9.17% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $11.1M +$1.75M +18.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
2019 $9.32M +$1.61M +20.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $7.71M +$4K +0.05% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 $7.71M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.